isoflurane has been researched along with thromboxane b2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaise, GA; Laurin, S; Moutquin, JM; Omri, A; Parent, M; Reader, TA | 1 |
| Hatano, Y; Hirakata, H; Mori, K; Nakamura, K; Narumiya, S; Sai, S; Toda, H; Urabe, N; Ushikubi, F | 1 |
2 other study(ies) available for isoflurane and thromboxane b2
| Article | Year |
|---|---|
Platelet-induced vasomotion of isolated canine coronary artery in the presence of halothane or isoflurane.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Platelets; Coronary Vasospasm; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Female; Halothane; Humans; Isoflurane; Male; Muscle, Smooth, Vascular; Platelet Activation; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Serotonin; Thromboxane A2; Thromboxane B2; Vasoconstriction; Vasoconstrictor Agents; Vasomotor System | 1994 |
Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity.
Topics: Adenosine Diphosphate; Anesthetics, Inhalation; Arachidonic Acid; Binding Sites; Drug Interactions; Epinephrine; Ethers; Halothane; Humans; Isoflurane; Methyl Ethers; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Radioimmunoassay; Sevoflurane; Thromboxane A2; Thromboxane B2 | 1996 |